advertisement
11.9 Gene therapy (329)
Showing records 1 to 25
Display only abstracts from IGR 18-3 in classification 11.9 Gene therapy
Search within classification 11.9 Gene therapy94595 Long-Term Decrease of Intraocular Pressure in Rats by Viral Delivery of miR-146a
Luna C
Translational vision science & technology 2021; 10: 14 (IGR: 22-2)
94585 Optogenetic Modulation of Intraocular Pressure in a Glucocorticoid-Induced Ocular Hypertension Mouse Model
Kowal TJ; Prosseda PP
Translational vision science & technology 2021; 10: 10 (IGR: 22-2)
94595 Long-Term Decrease of Intraocular Pressure in Rats by Viral Delivery of miR-146a
Parker M; Challa P
Translational vision science & technology 2021; 10: 14 (IGR: 22-2)
94585 Optogenetic Modulation of Intraocular Pressure in a Glucocorticoid-Induced Ocular Hypertension Mouse Model
Ning K
Translational vision science & technology 2021; 10: 10 (IGR: 22-2)
94595 Long-Term Decrease of Intraocular Pressure in Rats by Viral Delivery of miR-146a
Gonzalez P
Translational vision science & technology 2021; 10: 14 (IGR: 22-2)
94585 Optogenetic Modulation of Intraocular Pressure in a Glucocorticoid-Induced Ocular Hypertension Mouse Model
Wang B; Alvarado J; Sendayen BE; Jabbehdari S; Stamer WD; Hu Y; Sun Y
Translational vision science & technology 2021; 10: 10 (IGR: 22-2)
92500 Inner retinal injury in experimental glaucoma is prevented upon AAV mediated Shp2 silencing in a caveolin dependent manner
Abbasi M
Theranostics 2021; 11: 6154-6172 (IGR: 22-1)
92783 Effect of connective tissue growth factor gene editing using adeno-associated virus-mediated CRISPR-Cas9 on rabbit glaucoma filtering surgery outcomes
Lee EJ
Gene Therapy 2021; 28: 277-286 (IGR: 22-1)
92634 Use of Gene Therapy in Retinal Ganglion Cell Neuroprotection: Current Concepts and Future Directions
Rhee J
Biomolecules 2021; 11: (IGR: 22-1)
92683 Gene therapy in the anterior eye segment
Amador C; Shah R
Current Gene Therapy 2022; 22: 104-131 (IGR: 22-1)
92634 Use of Gene Therapy in Retinal Ganglion Cell Neuroprotection: Current Concepts and Future Directions
Shih KC
Biomolecules 2021; 11: (IGR: 22-1)
92783 Effect of connective tissue growth factor gene editing using adeno-associated virus-mediated CRISPR-Cas9 on rabbit glaucoma filtering surgery outcomes
Han JC
Gene Therapy 2021; 28: 277-286 (IGR: 22-1)
92500 Inner retinal injury in experimental glaucoma is prevented upon AAV mediated Shp2 silencing in a caveolin dependent manner
Gupta VK
Theranostics 2021; 11: 6154-6172 (IGR: 22-1)
92783 Effect of connective tissue growth factor gene editing using adeno-associated virus-mediated CRISPR-Cas9 on rabbit glaucoma filtering surgery outcomes
Park DY
Gene Therapy 2021; 28: 277-286 (IGR: 22-1)
92500 Inner retinal injury in experimental glaucoma is prevented upon AAV mediated Shp2 silencing in a caveolin dependent manner
Chitranshi N
Theranostics 2021; 11: 6154-6172 (IGR: 22-1)
92683 Gene therapy in the anterior eye segment
Ghiam S; Kramerov AA
Current Gene Therapy 2022; 22: 104-131 (IGR: 22-1)
92500 Inner retinal injury in experimental glaucoma is prevented upon AAV mediated Shp2 silencing in a caveolin dependent manner
Gupta V
Theranostics 2021; 11: 6154-6172 (IGR: 22-1)
92783 Effect of connective tissue growth factor gene editing using adeno-associated virus-mediated CRISPR-Cas9 on rabbit glaucoma filtering surgery outcomes
Cho J
Gene Therapy 2021; 28: 277-286 (IGR: 22-1)
92683 Gene therapy in the anterior eye segment
Ljubimov AV
Current Gene Therapy 2022; 22: 104-131 (IGR: 22-1)
92500 Inner retinal injury in experimental glaucoma is prevented upon AAV mediated Shp2 silencing in a caveolin dependent manner
Ranjbaran R
Theranostics 2021; 11: 6154-6172 (IGR: 22-1)
92783 Effect of connective tissue growth factor gene editing using adeno-associated virus-mediated CRISPR-Cas9 on rabbit glaucoma filtering surgery outcomes
Kee C
Gene Therapy 2021; 28: 277-286 (IGR: 22-1)
92500 Inner retinal injury in experimental glaucoma is prevented upon AAV mediated Shp2 silencing in a caveolin dependent manner
Rajput R; Pushpitha K; Kb D; You Y; Salekdeh GH; Parton RG; Mirzaei M; Graham SL
Theranostics 2021; 11: 6154-6172 (IGR: 22-1)
90866 Reprogramming to recover youthful epigenetic information and restore vision
Lu Y
Nature 2020; 588: 124-129 (IGR: 21-4)
91724 Ad- and AAV8-mediated gene therapy in a murine model with retinal ischemia/reperfusion injuries
Luo J
Molecular therapy. Methods & clinical development 2021; 20: 551-558 (IGR: 21-4)
91599 Gene Therapy Strategies for Glaucomatous Neurodegeneration
Lani-Louzada R; Dias MS
Current Gene Therapy 2021; 0: (IGR: 21-4)
